BWXT to supply Ac-225 generation to Fusion Pharmaceuticals
BWX Technologies subsidiary BWXT Medical has agreed to provide Fusion Pharmaceuticals with generators to produce actinium-225, a medical isotope used to treat cancer in clinical trials.
BWX Technologies subsidiary BWXT Medical has agreed to provide Fusion Pharmaceuticals with generators to produce actinium-225, a medical isotope used to treat cancer in clinical trials.
Oklo to collaborate with Atomic Alchemy on isotope production
Fast reactor developer Oklo, which recently went public on the New York Stock Exchange, announced on May 13 that it has signed a memorandum of understanding with Atomic Alchemy to cooperate on...
Strontium: Supply-and-demand success for the DOE’s Isotope Program
The Department of Energy’s Isotope Program (DOE IP) announced last week that it would end its “active standby” capability for strontium-82 production about two decades after beginning...
Framatome, KHNP to investigate producing Lu-177 in South Korea
Framatome and Korea Hydro & Nuclear Power (KHNP) have announced the signing of a memorandum of understanding to explore the possibility of producing the medical isotope lutetium-177 at...
Radioisotopes target cancer, improve imaging, and have myriad other medical uses
On August 2, 1946, 1 millicurie of the isotope carbon-14 left Oak Ridge National Laboratory, bound for the Barnard Free Skin and Cancer Hospital in St. Louis, Mo.That tiny amount of the...
The road to wellness: The task of getting lifesaving medical isotopes to patients
According to the Council on Radionuclides and Radiopharmaceuticals, more than 82,000 nuclear imaging procedures using nuclear medicine are performed throughout the world every day. To ...
Germany’s ITM receives material license to produce Lu-177
Radiopharmaceutical biotech company ITM Isotope Technologies Munich announced it has received regulatory approval to begin production of the medical radioisotope lutetium-177 at the...
Framatome to work with Romania’s Nuclearelectrica on Lu-177 production
Framatome and Nuclearelectrica, operator of Romania’s Cernavoda nuclear power plant, announced the signing of a memorandum of understanding to explore the possibility of producing the...
Nucleus RadioPharma to receive Lu-177 under agreement with SHINE
Wisconsin-based fusion technology company SHINE Technologies has signed a long-term supply agreement with Nucleus RadioPharma for the supply of lutetium-177, a radioisotope used in cancer...
Canadian-German joint venture to produce medical Ac-225
German-based radiopharmaceutical biotech company ITM Isotope Technologies Munich and Canadian Nuclear Laboratories are launching a new joint venture company for the industrial-scale production...
SEC files lawsuit against nuclear battery startup
The Securities and Exchange Commission is suing nuclear battery developer NDB Inc., charging that the company and its chief executive officer, Nima Golsharifi, defrauded investors by making...